
Waters Corp
NYSE:WAT

US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
282.7
417.28
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

Intrinsic Value
The intrinsic value of one
WAT
stock under the Base Case scenario is
282.06
USD.
Compared to the current market price of 364.36 USD,
Waters Corp
is
Overvalued by 23%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Waters Corp
Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.

Valuation History
Historical valuation for WAT cannot be conducted due to limitations such as insufficient data or other constraints.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:

The rapid consolidation of key pharmaceutical clients, combined with pressured R&D budgets, could curtail demand for Waters’ premium chromatography and mass spectrometry instruments, putting a cap on near-term revenue growth.
Strong competition from larger players such as Thermo Fisher Scientific and Agilent, which can bundle products and services more effectively, risks eroding Waters’ market share in critical segments like biopharma and food safety testing.
Waters’ heavy reliance on a specialized product lineup leaves it vulnerable to niche market downturns or technological disruption, potentially limiting its ability to adapt quickly to shifting research priorities in life sciences.
Waters’ leadership in high-end liquid chromatography and mass spectrometry makes its instruments indispensable for cutting-edge pharmaceutical and biopharmaceutical research, positioning it to capture growth from increasing biologics development pipelines.
Ongoing investments in new product launches, such as advanced mass spectrometry tools and informatics solutions, should expand Waters’ addressable market and deepen relationships with both academic and industrial clients.
Waters maintains a robust service model and strong customer loyalty, reflected in recurring revenues from consumables and software, which help stabilize its cash flows and reinforce its premium brand reputation.

Revenue & Expenses Breakdown
Waters Corp
Balance Sheet Decomposition
Waters Corp
Current Assets | 1.7B |
Cash & Short-Term Investments | 326.3m |
Receivables | 733.4m |
Other Current Assets | 609.5m |
Non-Current Assets | 2.9B |
PP&E | 725.4m |
Intangibles | 1.9B |
Other Non-Current Assets | 295.7m |
Current Liabilities | 789.8m |
Accounts Payable | 99.9m |
Accrued Liabilities | 131.1m |
Other Current Liabilities | 558.7m |
Non-Current Liabilities | 1.9B |
Long-Term Debt | 1.6B |
Other Non-Current Liabilities | 309m |
Free Cash Flow Analysis
Waters Corp
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Waters Corp
Revenue
|
3B
USD
|
Cost of Revenue
|
-1.2B
USD
|
Gross Profit
|
1.8B
USD
|
Operating Expenses
|
-920.3m
USD
|
Operating Income
|
839m
USD
|
Other Expenses
|
-201.2m
USD
|
Net Income
|
637.8m
USD
|
WAT Profitability Score
Profitability Due Diligence
Waters Corp's profitability score is 69/100. The higher the profitability score, the more profitable the company is.

Score
Waters Corp's profitability score is 69/100. The higher the profitability score, the more profitable the company is.
WAT Solvency Score
Solvency Due Diligence
Waters Corp's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Score
Waters Corp's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
WAT Price Targets Summary
Waters Corp
According to Wall Street analysts, the average 1-year price target for
WAT
is 415.14 USD
with a low forecast of 346.54 USD and a high forecast of 472.5 USD.
Dividends
Current shareholder yield for WAT is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
WAT
stock under the Base Case scenario is
282.06
USD.
Compared to the current market price of 364.36 USD,
Waters Corp
is
Overvalued by 23%.